Warning: The NCBI web site requires JavaScript to function. more...
Smoking and nicotine exposure delay development of collagen-induced arthritis in mice.
Lindblad SS, Mydel P, Jonsson IM, Senior RM, Tarkowski A, Bokarewa M.
Arthritis Res Ther. 2009;11(3):R88. Epub 2009 Jun 11.
Related citations
Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
Joosten LA, Lubberts E, Helsen MM, Saxne T, Coenen-de Roo CJ, Heinegård D, van den Berg WB.
Arthritis Res. 1999;1(1):81-91. Epub 1999 Oct 26.
The vagus nerve and nicotinic receptors involve inhibition of HMGB1 release and early pro-inflammatory cytokines function in collagen-induced arthritis.
Li T, Zuo X, Zhou Y, Wang Y, Zhuang H, Zhang L, Zhang H, Xiao X.
J Clin Immunol. 2010 Mar;30(2):213-20. Epub 2009 Nov 5.
Effect of actarit on type II collagen-induced arthritis in mice.
Fujisawa H, Nishimura T, Motonaga A, Inoue Y, Inoue K, Suzuka H, Yoshifusa H, Kimura K, Muramatsu M.
Arzneimittelforschung. 1994 Jan;44(1):64-8.
Interferon-gamma production in response to in vitro stimulation with collagen type II in rheumatoid arthritis is associated with HLA-DRB1(*)0401 and HLA-DQ8.
Berg L, Rönnelid J, Sanjeevi CB, Lampa J, Klareskog L.
Arthritis Res. 2000;2(1):75-84.
Etiological role of cigarette smoking in rheumatoid arthritis: Nasal exposure to cigarette smoke condensate extracts augments the development of collagen-induced arthritis in mice.
Okamoto S, Adachi M, Chujo S, Yamada K, Akita K, Itoh S, Takii T, Hayakawa K, Onozaki K.
Biochem Biophys Res Commun. 2011 Jan 28;404(4):1088-92. Epub 2010 Dec 30.
IgG antibodies to type II collagen reflect inflammatory activity in patients with rheumatoid arthritis.
Kim WU, Yoo WH, Park W, Kang YM, Kim SI, Park JH, Lee SS, Joo YS, Min JK, Hong YS, Lee SH, Park SH, Cho CS, Kim HY.
J Rheumatol. 2000 Mar;27(3):575-81.
Prevention of collagen-induced arthritis (CIA) by treatment with polyethylene glycol-conjugated type II collagen; distinct tolerogenic property of the conjugated collagen from the native one.
Ito HO, So T, Ueda T, Imoto T, Koga T.
Clin Exp Immunol. 1997 May;108(2):213-9.
FR180204, a novel and selective inhibitor of extracellular signal-regulated kinase, ameliorates collagen-induced arthritis in mice.
Ohori M, Takeuchi M, Maruki R, Nakajima H, Miyake H.
Naunyn Schmiedebergs Arch Pharmacol. 2007 Jan;374(4):311-6. Epub 2006 Nov 23.
Tracking of proinflammatory collagen-specific T cells in early and late collagen-induced arthritis in humanized mice.
Svendsen P, Andersen CB, Willcox N, Coyle AJ, Holmdahl R, Kamradt T, Fugger L.
J Immunol. 2004 Dec 1;173(11):7037-45.
TNF-alpha antibodies and osteoprotegerin decrease systemic bone loss associated with inflammation through distinct mechanisms in collagen-induced arthritis.
Saidenberg-Kermanac'h N, Corrado A, Lemeiter D, deVernejoul MC, Boissier MC, Cohen-Solal ME.
Bone. 2004 Nov;35(5):1200-7.
TNF receptor gene therapy results in suppression of IgG2a anticollagen antibody in collagen induced arthritis.
Mukherjee P, Wu B, Mayton L, Kim SH, Robbins PD, Wooley PH.
Ann Rheum Dis. 2003 Aug;62(8):707-14.
Oral administration of type-II collagen peptide 250-270 suppresses specific cellular and humoral immune response in collagen-induced arthritis.
Zhu P, Li XY, Wang HK, Jia JF, Zheng ZH, Ding J, Fan CM.
Clin Immunol. 2007 Jan;122(1):75-84. Epub 2006 Oct 11.
Dichloroacetate alleviates development of collagen II-induced arthritis in female DBA/1 mice.
Bian L, Josefsson E, Jonsson IM, Verdrengh M, Ohlsson C, Bokarewa M, Tarkowski A, Magnusson M.
Arthritis Res Ther. 2009;11(5):R132. Epub 2009 Sep 1.
Anti-inflammatory effect of bee venom on type II collagen-induced arthritis.
Lee JD, Kim SY, Kim TW, Lee SH, Yang HI, Lee DI, Lee YH.
Am J Chin Med. 2004;32(3):361-7.
Arginine-rich anti-vascular endothelial growth factor (anti-VEGF) hexapeptide inhibits collagen-induced arthritis and VEGF-stimulated productions of TNF-alpha and IL-6 by human monocytes.
Yoo SA, Bae DG, Ryoo JW, Kim HR, Park GS, Cho CS, Chae CB, Kim WU.
J Immunol. 2005 May 1;174(9):5846-55.
Suppression of collagen-induced arthritis by single administration of poly(lactic-co-glycolic acid) nanoparticles entrapping type II collagen: a novel treatment strategy for induction of oral tolerance.
Kim WU, Lee WK, Ryoo JW, Kim SH, Kim J, Youn J, Min SY, Bae EY, Hwang SY, Park SH, Cho CS, Park JS, Kim HY.
Arthritis Rheum. 2002 Apr;46(4):1109-20.
Amelioration of collagen-induced arthritis by blockade of inducible costimulator-B7 homologous protein costimulation.
Iwai H, Kozono Y, Hirose S, Akiba H, Yagita H, Okumura K, Kohsaka H, Miyasaka N, Azuma M.
J Immunol. 2002 Oct 15;169(8):4332-9.
Characterization of a peptide analog of a determinant of type II collagen that suppresses collagen-induced arthritis.
Myers LK, Tang B, Rosloniec EF, Stuart JM, Chiang TM, Kang AH.
J Immunol. 1998 Oct 1;161(7):3589-95.
Suppressive effect of hochu-ekki-to on collagen induced arthritis in DBA1J mice.
Hai le X, Kogure T, Niizawa A, Fujinaga H, Sakakibara I, Shimada Y, Watanabe H, Terasawa K.
J Rheumatol. 2002 Aug;29(8):1601-8.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on